Small Cap Losers: INMB, SCR, LMAT
3:06 pm Wednesday, July 14th, 2021
INmune Bio Inc (NASDAQ:INMB) stock fell 13% after the company entered into an agreement with a healthcare focused institutional investor and a family office for the purchase and sale of 1,818,182 of its common shares, priced at $22.00/share. Co intends to put proceeds in part toward pipeline expansion and advancing the development of its product candidates. Pulls back from yesterday’s five-month highs.
Score Media and Gaming Inc (NASDAQ:SCR) slid 11% to $15.80 after the company reported Q3 results; media revs increased +270% yr/yr and +5% vs the same period in 2019; negative net gaming revs of C$(2.5) million partially offset results. Total Q3 gaming handle on theScore Bet was C$73.0 million. EBITDA loss widened yr/yr due to expenses associated with the expansion of co’s gaming operations and costs related to co’s US IPO. Drops to its lowest levels since May.
LeMaitre Vascular Inc (NASDAQ:LMAT) stock decreased by 9% to $54.52 after the company announced a public offering of 1.0 million common shares, priced at $54.50/share. Also issued upside guidance for Q2 revs; co sees net sales up +64% on a reported basis, supported by Artegraft, and +35% yr/yr organically. Co expects a gross margin decline of -2.7% at the midpoint yr/yr, driven by inventory write-downs and manufacturing inefficiencies.
